Abstract:Xiao Hu, 1 Feifei Yang, 2 Yonghong Liao, 2 Lin Li, 1 Guoguang Zhao, 3 Lan Zhang 1 1 Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, People's Republic of China; 2 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, People's Republic of China; 3 Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing 100053, People's Republic of China Correspondence: Guoguang Zhao; Lan Zhang Email ggzhao@vip.sina.com; lanizhg@126.com Background and Aim: Polymeric nanoparticles (NPs) have received much attention as promising carrier systems in lung cancer and brain metastases. Methods: Here, for the first time, we investigated the feasibility of using inhaled cholesterol-PEG co-modified poly (n-butyl) cyanoacrylate NPs (CLS-PEG NPs) of docetaxel (DTX) for sustained pulmonary drug delivery in cancer metastasis. Results: Spray-dried or freeze-dried NPs yielded sustained drug release in vitro. In vitro inhalation evaluation data indicated that the inhalation formulation had better inhalability. Compared with intravenous (IV) administration, pharmacokinetic data suggested that the inhalation formulation prolonged plasma concentration of DTX for greater than 24 h and is more quickly and completely absorbed into the rat lung after intratracheal (IT) administration. Furthermore, freeze-dried powders were found to increase the t 1/2 and area under curve (AUC) by 2.3 and 6.5 fold compared to the free drug after IT administration, and spray-dried powders were found to increase the t 1/2 and AUC by 3.4 and 8.8 fold, respectively. After pulmonary administration of the inhalation formulation, DTX appeared to prolong the pulmonary absorption time. In addition, the inhalation formulation was distributed to the brain in a sustained release manner. Conclusion: These experimental results demonstrated that freeze- and spray-dried powders have the potential for pulmonary sustained release, and they also have the potential to be used as a novel treatment for the delivery of drugs that pass through the air–blood barrier and enter the brain and are efficient carriers for the treatment of brain metastasis. Keywords: pulmonary delivery, docetaxel, lung cancer, spray-drying, dry powder

Inhalable Cyclodextrin Metal-Organic Framework Dry Powder Enhanced Direct Pulmonary Delivery of Paclitaxel for the Treatment of Lung Cancer

Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation

Inhalable Dry Powder Prepared from Folic Acid-Conjugated Docetaxel Liposomes Alters Pharmacodynamic and Pharmacokinetic Properties Relevant to Lung Cancer Chemotherapy.

Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment

Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation

Development of Aerosol Dry Powder Chemotherapeutic-Loaded Microparticles for the Treatment of Lung Cancer

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

Preparation and evaluation of inhaled dry powders based on folic acid-conjugated Docetaxel nanoparticles

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation

Highly efficient pulmonary delivery of levo-tetrahydropalmatine using γ-cyclodextrin metal-organic framework as a drug delivery platform

Inhaled Multilevel Size-Tunable, Charge-Reversible and Mucus-Traversing Composite Microspheres As Trojan Horse: Enhancing Lung Deposition and Tumor Penetration

Facile Preparation of Paclitaxel Nano-Suspensions to Treat Lung Cancer

Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer

Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer Therapy

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery

Inhalable Functional Mixed-Polymer Microspheres to Enhance Doxorubicin Release Behavior for Lung Cancer Treatment

Nano-Porous Silica Aerogels As Promising Biomaterials for Oral Drug Delivery of Paclitaxel.

Pulmonary Delivery of Docetaxel and Celecoxib by PLGA Porous Microparticles for Their Synergistic Effects Against Lung Cancer

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Optimizing adjuvant inhaled chemotherapy: Synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach